knowledge -WSS

knowledge

author：leisure time 2025-10-01 00:52:48 - browse：33

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： STAT Readout Newsletter: Today's biggest biotech updates

WSS

Patient advocates debate FDA's accelerated approval process

Oprah kicked off a national conversation on obesity. Let's have it

Vertex Pharmaceuticals may move headquarters in Boston

The Readout: Lenmeldy, GLP

Roche subsidiary Foundation Medicine opens new headquarters

Readout LOUD podcast: mifepristone case, GLP

Wikipedia

knowledge

Wikipedia

Heart attack and stroke risk calculators need revising

Hospital price transparency does save money, advocate argues

23andMe had bad news about my health. I wish a person had delivered it

Researchers explore possible ties between long Covid, menopause

Walensky prepares to leave CDC — and Congress — behind

States should stop sabotaging methadone treatment reform

New air purifier tech could be key to improving indoor air quality

Pharmacists can make shortage drugs, but at what cost?

The cancer drug shortage isn’t new — and neither are the solutions

Eliminate the waiting period for sterilization covered by Medicaid

leisure time

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

FDA gives detailed accounting of AI

The explosion of genetic testing requires a new approach

Merck drug for rare lung condition set for approval in U.S.

Medicare reduced heart disease by changing how it pays doctors

STAT Summit: Biotech founders on deal

explore

focus

entertainment

Wikipedia